Efficacy of a neuropsychological training programme for patients with multiple sclerosis - a randomised controlled trial

被引:0
|
作者
Tesar, N [1 ]
Bandion, K [1 ]
Baumhackl, U [1 ]
机构
[1] Landesklinikum St Polten, Neurol Abt, A-3100 St Polten, Austria
关键词
multiple sclerosis; cognitive impairments; cognitive training; compensation mechanisms; subjective everyday relevance;
D O I
10.1007/s00508-005-0470-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: One aim of this project was to investigate the efficacy of a specific training programme for MS patients, which also contained compensation strategies and relaxation exercises relevant to everyday life. The other aim was to check the programme's relevance to everyday life. Method. 19 patients, randomised into two groups, took part in the study. The participants in the treated group completed a specific neurological training programme which began immediately after the basic testing (visit 1) and lasted 4 weeks, with a total of 12 sessions. The monitoring test was done immediately after the training programme (at visit 2) and the follow-up was 3 months later (visit 3). Both study groups were fully comparable as regards clinical and socio-demographic data and baseline intelligence level. Results: The results of the cognitive training programme were especially evident in the significant improvements in executive functions (CKV) and spatial-constructional abilities (HAWIE-R). Comparison between the treated and the control group showed no significant difference in the fatigue values (MFIS). However, when the treated group was examined over the three times of measurements, the symptoms of fatigue had diminished significantly. Regarding memory, comparison of the groups showed no changes; within the treated group, however, the verbal (VLT) and non-verbal learning and memory (NVLT) improved significantly. The results for sustained attention improved in both groups over time. It must be assumed that a learning effect had occurred here. The depression values (BDI) also improved in both study groups. The follow-up questionnaire showed that 60% (6) attributed an average to above-average benefit to the training. Conclusion: To summarise, it is apparent that MS patients with mild to moderate cognitive impairment are able to profit from even a fairly brief neuropsychological training programme and to integrate much of it into their everyday lives. In view of this, it would seem appropriate to offer such a programme as standard, associated with medication.
引用
收藏
页码:747 / 754
页数:8
相关论文
共 50 条
  • [21] Treadmill training for individuals with multiple sclerosis: a pilot randomised trial
    van den Berg, M
    Dawes, H
    Wade, DT
    Newman, M
    Burridge, J
    Izadi, H
    Sackley, CM
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (04): : 531 - 533
  • [22] Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients
    Maeurer, M.
    Ortler, S.
    Baier, M.
    Meergans, M.
    Scherer, P.
    Hofmann, W. E.
    Tracik, F.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 631 - 638
  • [23] The effect of bright light therapy on fatigue in Multiple Sclerosis patients - a randomised controlled trial
    Voggenberger, L.
    Boeck, M.
    Leutmezer, F.
    Moser, D.
    Seidel, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 637 - 637
  • [24] Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial
    Gandolfi, Marialuisa
    Munari, Daniele
    Geroin, Christian
    Gajofatto, Alberto
    Benedetti, Maria Donata
    Midiri, Alessandro
    Carla, Fontana
    Picelli, Alessandro
    Waldner, Andreas
    Smania, Nicola
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (11) : 1453 - 1462
  • [25] Efficacy of stress management training for hypertension: A randomised controlled trial
    Sanz, Jesus
    Garcia Vera, Maria Paz
    Magan, Ines
    Espinosa, Regina
    Fortun, Maria
    INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2012, 47 : 436 - 437
  • [26] Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial
    Gogem Topcu
    Laura Smith
    Jacqueline R. Mhizha-Murira
    Nia Goulden
    Zoë Hoare
    Avril Drummond
    Deborah Fitzsimmons
    Nikos Evangelou
    Klaus Schmierer
    Emma C. Tallantyre
    Paul Leighton
    Kimberley Allen-Philbey
    Andrea Stennett
    Paul Bradley
    Clare Bale
    James Turton
    Roshan das Nair
    Pilot and Feasibility Studies, 8
  • [27] Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial
    Topcu, Gogem
    Smith, Laura
    Mhizha-Murira, Jacqueline R.
    Goulden, Nia
    Hoare, Zoe
    Drummond, Avril
    Fitzsimmons, Deborah
    Evangelou, Nikos
    Schmierer, Klaus
    Tallantyre, Emma C.
    Leighton, Paul
    Allen-Philbey, Kimberley
    Stennett, Andrea
    Bradley, Paul
    Bale, Clare
    Turton, James
    das Nair, Roshan
    PILOT AND FEASIBILITY STUDIES, 2022, 8 (01)
  • [28] Computer assisted cognitive training improves neuropsychological functions and cognitive fatigue in patients with secondary progressive Multiple Sclerosis: a randomized controlled trial
    Messinis, L.
    Kosmidis, M. H.
    Nasios, G.
    Konitsiotis, S.
    Ntoskou, A.
    Bakirtzis, C.
    Grigoriadis, N.
    Papathanasopoulos, P.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 798 - 798
  • [29] Effect of videogame-based physical activity training in persons with multiple sclerosis: a randomised controlled trial
    Ozdogar, A. T.
    Ertekin, O.
    Kahraman, T.
    Yigit, P.
    Ozakbas, S.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 674 - 674
  • [30] Training reactive balance using trips and slips in people with multiple sclerosis: A blinded randomised controlled trial
    Okubo, Yoshiro
    Suhaimy, Mohamed Suhair Bin Mohamed
    Hoang, Phu
    Chaplin, Carly
    Hicks, Cameron
    Sturnieks, Daina L.
    Lord, Stephen R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 73